Can platelet purinergic receptors be targeted to safely treat non-thrombotic diseases?

Clive Page,
Professor of Pharmacology,King's College London, London, United Kingdom

Dingxin Pan,
Postdoctoral Fellow,King's College London, London, United Kingdom

Platelet activation during inflammation and evidence for biased signalling via P2Y1
Dr Simon Pitchford
Senior Lecturer in Pharmacology, King's College London, London, United Kingdom

The role of the platelet P2Y12 receptor in inflammation
Professor Robert Storey
Professor of Cardiology, University of Sheffield, Sheffield, United Kingdom

Oral communication speaker - to be confirmed in 2022.

The Role of P2Y1 and P2Y14 receptors in non-thrombotic platelet functions
Kate Arkless
King's College London United Kingdom, London, United Kingdom

Novel pharmacophores and ligand docking analyses to probe P2Y1 and P2Y12 receptor activation.
Professor Kenneth Jacobson
National Institutes of Health, Bethesda, The United States of America